Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
Clinical trial NCT06400368 · UNKNOWN
Trial details
- NCT number
- NCT06400368
- Sponsor
- NeuroVision Imaging
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-24
- Primary completion
- 2026-04-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.